ANVS – annovis bio, inc. (US:NASDAQ)
Stock Stats
News
Annovis Invited to Present at National Institute on Aging Workshop on Dementia with Lewy Bodies (DLB)
Annovis Bio, Inc. (NYSE: ANVS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Annovis Bio Reports Third Quarter Financial Results and Provides Business Update
Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Maria Maccecchini, CEO of Annovis Bio
Form 8-K Annovis Bio, Inc. For: Nov 12
Form 10-Q Annovis Bio, Inc. For: Sep 30
Form 8-K Annovis Bio, Inc. For: Oct 15
Form 8-K Annovis Bio, Inc. For: Sep 30
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.